Busca avançada
Ano de início
Entree


Dermatological Manifestations in COVID-19: A Case Study of SARS-CoV-2 Infection in a Genetic Thrombophilic Patient with Mthfr Mutation

Texto completo
Autor(es):
Celestino, Gabriela Gomes ; Amarante, Marla Karine ; Vespero, Eliana Carolina ; Tavares, Eliandro Reis ; Yamauchi, Lucy Megumi ; Candido, Erika Donizetti ; de Oliveira, Danielle Bruna Leal ; Durigon, Edison Luiz ; Yamada-Ogatta, Sueli Fumie ; Faccin-Galhardi, Ligia Carla
Número total de Autores: 10
Tipo de documento: Artigo Científico
Fonte: PATHOGENS; v. 12, n. 3, p. 11-pg., 2023-03-01.
Resumo

The present case study describes the dermatological manifestations of COVID-19 in a patient with genetic thrombophilia (MTHFR-C677T mutation) and the identification of a SARS-CoV-2 variant of interest (VOI). A female patient, 47 years old, unvaccinated, with thrombophilia, was diagnosed with COVID-19. She presented with urticarial and maculopapular eruptions from the seventh day of symptoms, which progressed to multiple lesions with dark centers (D-dimer value > 1450 ng/mL). The dermatological manifestations disappeared after 30 days, corroborating the reduction in D-dimer levels. Viral genome sequencing revealed infection by the VOI Zeta (P.2). Antibody testing, performed 30 days after the onset of symptoms, detected only IgG. The virus neutralization test showed the highest neutralizing titer for a P.2 strain, validating the genotypic identification. Lesions were suggested to be due to infection in skin cells causing a direct cytopathic effect or release of pro-inflammatory cytokines triggering erythematous and urticarial eruptions. In addition, vascular complications are also proposed to be due to the MTHFR mutation and increased D-dimer values. This case report is an alert about COVID-19 in patients with pre-existing vascular diseases, especially in unvaccinated patients, by VOI. (AU)

Processo FAPESP: 20/06409-1 - Avaliação da resposta imune humoral e da resposta inflamatória em pacientes com diagnóstico confirmado de COVID-19 no Hospital Sírio Libanês e correlação com a severidade da doença
Beneficiário:Edison Luiz Durigon
Modalidade de apoio: Auxílio à Pesquisa - Regular